Case Studies/GlaxoSmithKline

From Creative Commons
Revision as of 21:33, 20 August 2010 by CCID-jane (talk | contribs) (Created page with "{{Case Study |Description=GlaxoSmithKline (a UK pharmaceutical company) has waived all copyright restrictions to its malaria data set, which includes more than 13,000 compounds k...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search



Go to URL
License User
Curator
License Used
unspecified
Media
Data
Adoption date unspecified
United Kingdom
Tags
GSK, GlaxoSmithKline, malaria, disease
Translations

.


Evaluation Information.png
Page Importance:
Page Quality:
GlaxoSmithKline (a UK pharmaceutical company) has waived all copyright restrictions to its malaria data set, which includes more than 13,000 compounds known to be active against malaria.

—

Overview

GlaxoSmithKline is a UK pharmaceutical company that has released a data set of 13,500 known compounds known to be active against malaria. The data set is called Tres Cantos Antimalarial (TCAMS), and is available from the ChEMBL-NTD database, "a repository for Open Access primary screening and medicinal chemistry data directed at neglected diseases - endemic tropical diseases of the developing regions of the Africa, Asia, and the Americas."

License Usage

GlaxoSmithKline has waived all copyright restrictions to its malaria data set under the CC0 public domain waiver.

Motivations

Media

Retrieved from "https://wiki.creativecommons.org/index.php?title=Case_Studies/GlaxoSmithKline&oldid=40273"